Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5133 USD | -5.40% | +9.21% | -1.74% |
Chart calendar Kiora Pharmaceuticals, Inc.
Upcoming events on Kiora Pharmaceuticals, Inc.
Past events on Kiora Pharmaceuticals, Inc.
06/05/2024 02:30 am | Association for Research in Vision and Ophthalmology Meeting |
01/05/2024 10:30 pm | Annual General Meeting |
19/04/2024 12:00 am | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
11/04/2024 07:45 pm | Needham Healthcare Conference |
25/03/2024 04:30 pm | Q4 2023 Earnings Release |
01/02/2024 04:00 am | Business Update Call |
04/11/2023 09:45 pm | American Academy Of Ophthalmology Meeting |
17/10/2023 04:30 pm | Lytham Partners Fall Investor Conference |
31/08/2023 09:30 pm | Extraordinary Shareholders Meeting |
16/08/2023 09:30 am | HCW Ophthalmology Virtual Conference |
08/08/2023 04:30 pm | Q2 2023 Earnings Release |
22/06/2023 11:30 pm | OTC Life Science Investor Forum |
21/06/2023 07:30 pm | Annual General Meeting |
20/06/2023 07:30 pm | Maxim Group Virtual Healthcare Conference |
02/05/2023 03:56 am | American Society of Neuroradiology Meeting |
27/04/2023 11:15 pm | Association for Research in Vision and Ophthalmology Meeting - Poster No 5444 |
26/04/2023 02:00 am | Association for Research in Vision and Ophthalmology Meeting - Poster No 3544 |
25/04/2023 10:15 pm | Association for Research in Vision and Ophthalmology Meeting - Poster No 3123 |
09/11/2022 05:15 pm | Q3 2022 Earnings Release |
30/09/2022 12:00 am | Ladenburg Thalmann Healthcare Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2,69 2,69 0% | 0,01 0,03 -64% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 12,2 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -7,11 -7,43 4.38% | -8,21 -9,44 13.01% | -16,9 -11,3 -49.59% | -12,3 -13,0 5.59% | -12,6 -13,3 5.33% | -0,92 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,00 -7,32 4.35% | -8,08 -9,40 14.08% | -16,7 -11,0 -51.14% | -13,7 -14,5 5.22% | -12,4 -13,2 6.18% | -0,89 |
Net income Million USD | Released Forecast Spread | -7,10 -7,32 3.05% | -8,09 -9,21 12.13% | -16,4 -11,0 -48.38% | -13,6 -14,5 6% | -13,0 -13,4 2.79% | -0,89 |
EPS USD | Released Forecast Spread | -89,2 -83,6 -6.7% | -70,8 -80,8 12.38% | -70,8 -49,6 -42.74% | -18,6 -13,5 -37.82% | -2,69 -2,59 -3.99% | 0,00 |
Announcement Date | 04/03/20 | 25/03/21 | 15/04/22 | 23/03/23 | 25/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 8,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -8,65 -3,03 -185.22% | -3,57 -2,98 -19.6% | -2,40 -2,60 7.61% | -3,70 -2,68 -38.17% | -2,64 -3,36 21.67% | -1,92 -3,11 38.42% | -2,63 -2,55 -3.26% | -5,92 -2,70 -119.59% | -2,12 -2,83 25.06% | 5,40 | -3,14 | -3,21 | -3,28 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,68 -3,03 -186.32% | -3,57 -2,98 -19.45% | -2,40 -2,60 7.66% | -5,12 -2,68 -91.04% | -2,61 -3,36 22.36% | -1,87 -3,11 39.83% | -2,61 -2,54 -2.91% | -5,76 -2,69 -114.34% | -2,18 -2,82 22.76% | 5,41 | -3,13 | -3,20 | -3,27 |
Net income Million USD | Released Forecast Spread | -8,38 -3,03 -176.27% | -3,57 -2,98 -19.45% | -2,40 -2,60 7.66% | -5,12 -2,68 -91.04% | -2,50 -3,36 25.72% | -1,87 -3,11 39.83% | -2,61 -2,54 -2.91% | -6,29 -2,69 -134.09% | -2,27 -2,82 19.56% | 5,41 | -3,13 | -3,20 | -3,27 |
EPS USD | Released Forecast Spread | -31,2 -10,6 -194.34% | -10,8 -9,40 -14.89% | -7,20 -8,00 10% | -6,03 -4,16 -45.07% | -1,76 -2,46 28.57% | -1,00 -1,56 36.03% | -0,79 -1,11 29.04% | -0,89 -0,35 -151.89% | -0,39 | 0,28 | -0,08 | -0,08 | -0,09 |
Announcement Date | 15/04/22 | 08/07/22 | 12/08/22 | 09/11/22 | 23/03/23 | 09/05/23 | 08/08/23 | 09/11/23 | 25/03/24 | - | - | - | - |
Today 04:30 pm | BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Today 01:31 am | VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
07/05/2024 | COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
07/05/2024 | LYELL IMMUNOPHARMA, INC.: Q1 2024 Earnings Release (Projected) |
07/05/2024 | Y-MABS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
07/05/2024 | INNOCARE PHARMA LIMITED: Q1 2024 Earnings Release (Projected) |
07/05/2024 | PHILOGEN S.P.A.: Q1 2024 Earnings Release |
07/05/2024 04:30 pm | RHYTHM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
07/05/2024 04:30 pm | MADRIGAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
08/05/2024 01:31 am | HALOZYME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Past sector events for Kiora Pharmaceuticals, Inc.
Today | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
Today | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
Today | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
Today | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
Today | INHIBRX, INC.: Q1 2024 Earnings Release (Projected) |
Today | BIONTECH SE: Q1 2024 Earnings Release |
03/05/2024 04:30 pm | GH RESEARCH PLC: Q1 2024 Earnings Release |
03/05/2024 01:35 am | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
03/05/2024 01:35 am | ZYMEWORKS INC.: Q1 2024 Earnings Release |
03/05/2024 01:32 am | ARDELYX, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KPRX Stock
- Calendar Kiora Pharmaceuticals, Inc.